Results 201 to 210 of about 11,638,573 (298)

3,4-Bis(4-nitrophenyl)-1,2,5-oxadiazole 2-oxide

, 2008
Ghali Alhouari, Abdelali Kerbal, Najib Ben Larbi, Taïbi Ben Hadda, Maria Daoudi, H. Stoeckli‐Evans   +5 more
openalex   +1 more source

Design, synthesis, and apoptotic antiproliferative activity of novel dihydropyrimidine-5-carbonitrile/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors endowed with antioxidant activity. [PDF]

RSC Adv
Al-Wahaibi LH, Mohamed AM, Abou-Zied HA, Abdullah Alzahrani AY, Bräse S, Youssif BGM.   +5 more
europepmc   +1 more source

From Bench to Bioactivity: An Integrated Medicinal Development Based on Kinetic and Simulation Assessment of Pyrazolone-Oxadiazole Coupled Benzamide as Promising Inhibitors of Diabetes Mellitus. [PDF]

Pharmaceuticals (Basel)
Khowdiary MM, Felemban S.
europepmc   +1 more source

Synthesis of some new propanamide derivatives bearing 4- piperidinyl-1,3,4-oxadiazole, and their evaluation as promising anticancer agents

, 2018
Azizur Rehman, N Ahtzaz, MA Abbasi, Siddiqui Sz, Shahul Hameed Sukkur Saleem, Shaista Manzoor, J Iqbal, NA Virk, TA Chohan, Syed Adnan Alı Shah   +9 more
openalex   +2 more sources

Conversion of N₂ into oxadiazoles promoted by a multinuclear samarium complex. [PDF]

Nat Commun
Shi X, Yuan Q, Chen Y, Xi Z, Wei J.
europepmc   +1 more source

Structure-activity relationship and in silico study of unique bi-heterocycles: 5-[(2-amino-1,3-thiazol-4-yl)methyl]-1,3,4-oxadiazole-2-thiol derivatives

, 2019
Muhammad Athar Abbasi, Muhammad Ramzan, A Aziz-Ur-Rehman, Sabahat Zahra Siddiqui, Mubashir Hassan, Hussain Raza, Syed Adnan Alı Shah, Bushra Mirza, Sung‐Yum Seo   +8 more
openalex   +2 more sources

Developing pyrazole-oxadiazole conjugates as potent anti-tubercular agents: an <i>in silico</i> and <i>in vitro</i> approach. [PDF]

RSC Med Chem
Kumar SA, Besra G, Batt S, Chandrashekar VM, Singh M, Akshatha HS, Bhagyalalitha M, Pujar KG, Bidye D, Madhukumari, Pujar GV.   +10 more
europepmc   +1 more source

Insight into the Anticancer Potential of Imidazole-Based Derivatives Targeting Receptor Tyrosine Kinases. [PDF]

Pharmaceuticals (Basel)
Al-Hussain SA, Dawood DH, Farghaly TA, Abu Alnjaa AM, Zaki MEA.   +4 more
europepmc   +1 more source

Promising Norlabdane-Heterocyclic Hybrids: Synthesis, Structural Characterization and Antimicrobial Activity Evaluation. [PDF]

Pharmaceuticals (Basel)
Lungu L, Ciocarlan A, Mangalagiu II, Aricu A.   +3 more
europepmc   +1 more source

Thiocarbamoylimidates as Precursors of New 5-Amino-1,2,4-Triazole and Oxadiazole Derivatives In Silico Prediction of Absorption, Distribution, Metabolism, and Excretion Parameters. [PDF]

Chempluschem
Gatri O, Roisnel T, Cordier M, Dorcet V, Efrit ML, Fischmeister C.   +5 more
europepmc   +1 more source